CLPUB00728
Wang S.-G., Han B.-L., Duan H.-C., Chen Y.-S., Peng Z.-M.
Establishment of a cell line of extrahepatic bile duct carcinoma.
Zhonghua Shi Yan Wai Ke Za Zhi 14:67-68(1997)

PubMed=20111907; DOI=10.1007/s11033-010-9975-7
Liu Z.-H., He Y.-P., Zhou Y.-K., Zhang P., Qin H.-L.
Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM.
Mol. Biol. Rep. 38:3075-3082(2011)

CLPUB00275
Zach S., Birgin E., Ruckert F.
Primary cholangiocellular carcinoma cell lines.
J. Stem Cell Res. Transplant. 2:1013-1013(2015)

PubMed=29913454; DOI=10.1159/000490210
Yu G.-Y., Wang X., Zheng S.-S., Gao X.-M., Jia Q.-A., Zhu W.-W., Lu L., Jia H.-L., Chen J.-H., Dong Q.-Z., Lu M., Qin L.-X.
RA190, a proteasome subunit ADRM1 inhibitor, suppresses intrahepatic cholangiocarcinoma by inducing NF-KB-mediated cell apoptosis.
Cell. Physiol. Biochem. 47:1152-1166(2018)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007
Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y., Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S., Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)